InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,682.40
(
0.00%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.72
(
0.40%
)
Bitcoin
62,311.04
(
1.40%
)
Post# of 5468
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Preciouslife1

Send PM Follow Ignore
Followers 89
Posts 19102
Boards Moderated 4
Alias Born 11/05/2005

Preciouslife1

Re: None

Saturday, 03/26/2022 9:47:32 AM

Saturday, March 26, 2022 9:47:32 AM

Post# of 5468
FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant … By Reuters Staff

March 25 (Reuters) - The U.S. health regulator has determined that the current authorized dose of GlaxoSmithKline Plc and Vir Biotechnology’s antibody-based COVID-19 treatment is unlikely to be effective against the Omicron BA.2 variant, the companies said on Friday.

The agency updated its emergency use authorization fact sheet on the drug sotrovimab. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

https://www.reuters.com/article/health-coronavirus-gsk-fda/fda-says-current-dose-of-gsk-vir-covid-therapy-likely-not-effective-against-ba-2-variant-idUSL3N2VS3TX

Bull-markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria .. Sir John Templeton
Make your Life a Mission .... NOT an Intermission. † §|PL1|§

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up